Financial Performance Highlights - GoHealth achieved record revenue of $877 million for FY 2020, representing a 63% increase year-over-year[7, 12] - Adjusted EBITDA for FY 2020 reached $271 million, a 59% increase compared to the previous year[7, 12] - The Adjusted EBITDA margin for FY 2020 was 31%[8, 12] - Q4 2020 revenue was $446 million, a 55% increase year-over-year[12] - Q4 2020 Adjusted EBITDA was $170 million, a 31% increase year-over-year, with a 38% margin[12, 27] Growth and Efficiency - Total submissions for FY 2020 were 730,000, a 71% increase year-over-year[6, 12] - Medicare-Internal segment revenue growth was 110% for FY 2020 and 75% for Q4 2020[12] - The company's commissions receivable balance grew by 112% to $810 million in 2020[29, 31] Outlook for 2021 - Projected revenue for FY 2021 is estimated to be between $1.15 billion and $1.3 billion, representing a growth of 31% to 48%[14] - Adjusted EBITDA for FY 2021 is projected to be between $345 million and $385 million, a growth of 27% to 42%[14] - The Adjusted EBITDA margin for FY 2021 is expected to be around 30%[14]

ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO) complied with federal securities laws. On May 1, 2025, the Department of Justice filed a complaint against GoHealth and others alleging that the Company, among other things, “knowingly entered into unlawful agreements to present false or fraudulent claims to the Government and performed acts in furtherance of this conspiracy.” Following this news, the price of ...

GoHealth (GOCO) Conference Summary Company Overview - GoHealth specializes in helping Medicare consumers navigate their insurance options, particularly Medicare Advantage plans, which are growing rapidly in the market [4][15] - The company has been in operation for over 20 years and has facilitated over 30 million shopping experiences for Medicare consumers [9] Core Business Model - GoHealth provides a personalized shopping experience for Medicare consumers, focusing on their specific healthcare needs, such as doctor networks and drug coverage [7][10] - The company operates primarily through a telephonic model, where 100% of enrollments occur via live conversations with licensed agents [14] Market Dynamics - The Medicare Advantage market is growing at a rate of 5-7% annually, with approximately 68 million consumers in Medicare, half of whom are enrolled in Medicare Advantage plans [15][16] - Over 11,000 new Medicare consumers enter the market daily, with a majority opting for Medicare Advantage plans [16] Competitive Advantage - GoHealth claims to have the lowest customer acquisition cost (CAC) in the industry, being 17% better than public peers and nearly 50% better than the industry average [37] - The company utilizes a proprietary Plan Fit tool that leverages data from 30 million shopping experiences to match consumers with the best insurance plans [33][40] Recent Challenges and Strategic Adjustments - The company has faced challenges due to health plans being tentative about growth under the current economic model, leading to a pullback in writing new Medicare Advantage business [46][47] - GoHealth is diversifying its offerings by introducing guaranteed acceptance life insurance to stabilize agent productivity during slower periods in the Medicare market [55][58] Financial Performance - GoHealth reported material improvements in revenue and adjusted EBITDA for Q1 2024 compared to Q1 2025, driven by efficient resource deployment and an acquisition [38] - The company is working on resetting covenants with lenders due to changes in its business model and market dynamics [49][53] Future Outlook - The upcoming Annual Enrollment Period (AEP) is expected to be highly disruptive, which could lead to increased demand for GoHealth's services as consumers seek new plans [66][68] - The company anticipates a significant increase in revenue from its life insurance business in Q2 and Q3 2025 [63] Key Differentiators - GoHealth emphasizes an unbiased shopping experience, ensuring that agents recommend the best plans for consumers, even if it means advising them to stay on their current plans [21][27] - The company focuses on building long-term relationships with consumers, expecting them to return for multiple shopping experiences throughout their Medicare tenure [30] Conclusion - GoHealth is positioned in a growing market with a unique business model that prioritizes consumer needs and leverages technology to enhance efficiency and customer experience [39][88]

Core Insights - Bragar Eagel & Squire, P.C. is investigating potential claims against GoHealth, Inc. and Abacus Global Management, Inc. for possible violations of federal securities laws and unlawful business practices [1] GoHealth, Inc. (NASDAQ:GOCO) - The U.S. Department of Justice filed a False Claims Act complaint against GoHealth and other health insurance companies, alleging that from 2016 to at least 2021, they paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [2] - Following the DOJ's announcement, GoHealth's stock price dropped by $1.09 per share, a decline of 10.35%, closing at $9.44 per share on May 1, 2025 [2] Abacus Global Management, Inc. (NASDAQ:ABL) - Morpheus Research published a report alleging that Abacus Global Management is involved in an accounting scheme related to life settlements, which artificially inflates revenue by underestimating mortality rates [3] - In response to the report, Abacus Global's stock price fell by more than 21% [3]

NEW YORK, May 30, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen ...

Core Viewpoint - GoHealth, Inc. is initiated with a Strong Buy rating and a price target of $20, highlighting its position as a leading digital Medicare and health insurance brokerage utilizing AI for plan optimization and consumer activation in the U.S. [1] Group 1: Company Overview - GoHealth operates in the digital Medicare and health insurance brokerage marketplace, leveraging AI technology to enhance plan optimization and consumer engagement [1]. - The company is positioned to benefit from the growing demand for digital health insurance solutions in the U.S. market [1]. Group 2: Research Methodology - Moretus Research employs a structured framework to identify companies with durable business models and mispriced cash flow potential, focusing on U.S. public markets [1]. - The research emphasizes rigorous fundamental analysis combined with a judgment-driven process, avoiding noise and overly complex forecasting [1]. - Valuation methods are based on sector-relevant multiples tailored to each company's business model, emphasizing comparability and relevance [1]. Group 3: Investment Philosophy - Moretus Research aims to identify underappreciated companies undergoing structural changes or temporary dislocations, where disciplined analysis can lead to asymmetric returns [1]. - The research reflects a commitment to capital discipline and long-term compounding, raising the standard for independent investment research [1].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of GoHealth, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Investigation and Class Action - Shareholders who purchased GoHealth securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to GoHealth [2]. Group 2: Allegations and Stock Impact - The U.S. Department of Justice announced charges against GoHealth, alleging that from 2016 to 2021, the company was involved in illegal kickbacks totaling hundreds of millions of dollars to brokers for enrollments in Medicare Advantage plans [3]. - Following the announcement of these charges, GoHealth's stock price dropped by 10.3% on May 1, 2025, and an additional 6.7% on May 2, 2025 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been ranked in the top 4 for securities class action settlements since 2013 and recovered over $438 million for investors in 2019 alone [4].

Core Viewpoint - Cohen Milstein Sellers & Toll PLLC is investigating GoHealth, Inc. for potential securities fraud related to a Medicare Advantage kickback scheme following a complaint from the Department of Justice [1][5]. Group 1: Investigation Details - The U.S. Department of Justice filed a False Claims Act complaint against GoHealth, alleging that from 2016 to at least 2021, the company and several insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [5]. - Following the DOJ's lawsuit announcement, GoHealth's stock price dropped by $1.09 per share, or 10.35%, closing at $9.44 per share on May 1, 2025 [5]. Group 2: Investor Information - Investors who purchased shares of GoHealth between 2016 and May 1, 2025, are encouraged to contact Cohen Milstein for more information regarding the investigation [2]. - The law firm is actively seeking additional information and assistance related to the investigation [4]. Group 3: Law Firm Background - Cohen Milstein is recognized as one of the leading plaintiffs' law firms in the U.S., with a strong track record in securities litigation, having recovered billions for investors [7].

Financial Performance - Net revenues for Q1 2025 were $220,972,000, a 19% increase from $185,600,000 in Q1 2024[26] - Operating expenses totaled $214,303,000 in Q1 2025, up from $189,632,000 in Q1 2024, reflecting an increase of 13%[26] - The company reported an income from operations of $6,669,000 in Q1 2025, compared to a loss of $4,032,000 in Q1 2024[26] - Net loss attributable to GoHealth, Inc. was $4,408,000 in Q1 2025, an improvement from a net loss of $9,216,000 in Q1 2024[26] - The net income (loss) per share for Class A common stock was $(0.52) in Q1 2025, compared to $(1.04) in Q1 2024[26] - Comprehensive loss for Q1 2025 was $9,905,000, an improvement from a comprehensive loss of $21,351,000 in Q1 2024[30] - For the three months ended March 31, 2025, GoHealth reported a net loss of $9,786 thousand, compared to a net loss of $21,346 thousand for the same period in 2024, indicating a 54.2% improvement in net loss year-over-year[39] - Adjusted EBITDA for Q1 2025 was $42.060 million, a 56.4% increase from $26.894 million in Q1 2024, with an adjusted EBITDA margin of 19.0%[165] Assets and Liabilities - Total assets decreased to $1,382,067,000 as of March 31, 2025, down from $1,488,423,000 at the end of 2024[32] - Cash and cash equivalents decreased to $22,153,000 as of March 31, 2025, from $40,921,000 at the end of 2024[32] - Current liabilities decreased to $233,399,000 as of March 31, 2025, compared to $338,052,000 at the end of 2024[32] - The company had a total stockholders' equity of $397,086,000 as of March 31, 2025, down from $405,438,000 at the end of 2024[32] - As of March 31, 2025, the total long-term debt of the company is $446.4 million, a slight decrease from $447.9 million as of December 31, 2024[62] - The company reported a net cash used in operating activities of $12,405 thousand for Q1 2025, compared to net cash provided of $12,512 thousand in Q1 2024[39] - The company raised substantial doubt about its ability to continue as a going concern due to insufficient funding to meet obligations within the next twelve months[214] Revenue Sources - Medicare revenue increased to $219.404 million in Q1 2025, up 18.5% from $185.026 million in Q1 2024, driven by a significant rise in agency revenue[100] - Agency revenue, which includes commission revenue and partner marketing, reached $187.633 million in Q1 2025, a substantial increase of 89.4% compared to $99.124 million in Q1 2024[100] - The increase in net revenues was primarily driven by an $88.5 million rise in agency revenue, partially offset by a $54.1 million decrease in non-agency revenue[147] - The Company recognized $41.6 million in revenue from deferred revenue during Q1 2025, compared to $34.9 million in Q1 2024[110] Expenses - Share-based compensation increased to $2,803 thousand in Q1 2025 from $1,783 thousand in Q1 2024, reflecting a 57.0% increase[39] - Marketing and advertising expenses rose to $67.415 million in Q1 2025, a 27.7% increase from $52.775 million in Q1 2024, aimed at generating more qualified prospects[149] - General and administrative expenses increased by 33.9% to $22.656 million in Q1 2025, primarily due to costs associated with the e-TeleQuote acquisition[153] - Interest expense decreased to $15.954 million in Q1 2025 from $17.951 million in Q1 2024, reflecting a reduction in interest rates on the Term Loan Facility[155] Operational Changes - The company is currently in compliance with its financial covenants but faces substantial doubt about its ability to continue as a going concern due to potential liquidity constraints[50] - The company has developed mitigating plans to address potential liquidity constraints, including cost control measures and renegotiation of existing debt arrangements[50] - The company is actively looking to terminate or sublease certain office spaces and call centers as part of its cost savings initiatives[60] - The company completed the acquisition of e-TeleQuote on September 30, 2024, and excluded it from the internal control evaluation for the quarter ended March 31, 2025[207] Customer Engagement - Submissions increased to 303,026 in Q1 2025 from 216,148 in Q1 2024, indicating a significant growth in customer engagement[168] - For the three months ended March 31, 2025, the number of Submissions increased to 303,026, up 40.2% from 216,148 in the same period of 2024, primarily due to enhanced marketing efforts and increased agent headcount following the e-TeleQuote acquisition[170] Legal and Compliance - The company is contesting a derivative action related to alleged breaches of fiduciary duty, which may impact its financial condition[120] - The company is subject to various legal proceedings that could adversely affect its business and financial condition[213] - The company’s internal control over financial reporting was evaluated as effective as of March 31, 2025[205]

Core Insights - GoHealth Inc. (NASDAQ: GOCO) reported a strong performance in Q1 2025, with net revenues increasing by 19.1% year-over-year to $221.0 million, driven by a significant rise in submissions [1][7] - The company achieved an operating income of $6.7 million, a notable improvement from the previous year's loss, and Adj. EBITDA grew by 56.4% to $45.1 million, highlighting operational efficiencies [1][7] - GoHealth's growth is attributed to its leadership in the Medicare-focused digital health marketplace, supported by strategic investments in technology and operational excellence [1] Financial Performance - Q1 2025 net revenues reached $221.0 million, up from $185.6 million in the same period last year, reflecting a 19.1% increase [7] - The number of submissions in Q1 2025 was 303,026, representing a 40.2% increase compared to 216,148 submissions in Q1 2024 [7] - The company launched GoHealth Protect during the quarter, indicating a focus on innovation and market expansion [7]